28th December 2015
New Delhi, India
Antimicrobials, our lifeline to modern medicine, are today under grave threat, with antimicrobial resistance sitting alongside climate change and terrorism on the Global Risk Register, as a global public health priority for the UK. Globally, by 2050, drug-resistant infections could cause 10 million extra deaths a year and have a cumulative cost of US$ 100 […]
Read more on UK and India to work together to fight superbugs | Reply
11th April 2013
Bangalore, India
Research between India and the UK is growing and joint research funding between both countries now exceeds £100 million. An important strand in this research co-operation is health and biopharma. But if this research is to become real-world treatments and medical products, regulations in both countries will come into play. Therefore, regulations which support collaboration, […]
Read more on Understanding Indo-UK health regulations | Reply (2)
12th December 2012
New Delhi, India
Last week, UK Medicine and Healthcare products Regulatory Agency (MHRA) in association with UK Trade and Investment (UKTI) organised a series of seminars in India. The first seminar on the theme of UK regulatory procedures for pharmaceutical products was held in Mumbai on 3 December. The event brought together over 100 delegates from pharmaceutical and […]
Read more on The Medicine and Healthcare products Regulatory Agency of UK visits India | Reply
